StockNews.com Initiates Coverage on Calithera Biosciences (NASDAQ:CALA)

Equities researchers at StockNews.com began coverage on shares of Calithera Biosciences (NASDAQ:CALA) in a note issued to investors on Tuesday. The brokerage set a “hold” rating on the biotechnology company’s stock.

Calithera Biosciences Price Performance

NASDAQ CALA opened at $0.02 on Tuesday. The business has a 50-day moving average price of $0.02 and a 200-day moving average price of $0.03. Calithera Biosciences has a twelve month low of $0.01 and a twelve month high of $0.50.

About Calithera Biosciences

Calithera Biosciences, Inc operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc was incorporated in 2010 and is headquartered in South San Francisco, California.